期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older:A Dosing Interval Study—Yunnan Province,China,2021–2022
1
作者 Haitao Yang Xing Meng +10 位作者 Tingyu Zhuang cangning wang Zhongliang Yang Taotao Zhu Mei Li Yan Zheng Qianhui Wu Yaling Hu Hongjie Yu Xiaoqiang Liu Gang Zeng 《China CDC weekly》 SCIE CSCD 2023年第6期125-130,I0008-I0012,共11页
Summary What is already known about this topic?Neutralization levels induced by inactivated vaccines rapidly wane after primary immunization,and a homologous booster can recall specific immune memory,resulting in a re... Summary What is already known about this topic?Neutralization levels induced by inactivated vaccines rapidly wane after primary immunization,and a homologous booster can recall specific immune memory,resulting in a remarkable increase in antibody concentration.The optimal interval between primary and booster doses has yet to be determined. 展开更多
关键词 concentration. doses remarkable
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部